Login / Signup

Precise infliximab exposure and pharmacodynamic control to achieve deep remission in paediatric Crohn's disease (REMODEL-CD): study protocol for a multicentre, open-label, pragmatic clinical trial in the USA.

Phillip Paul MinarRuben J ColmanNanhua ZhangTomoyuki MizunoAlexander A Vinks
Published in: BMJ open (2024)
NCT05660746.
Keyphrases
  • clinical trial
  • open label
  • study protocol
  • phase ii
  • ulcerative colitis
  • double blind
  • phase iii
  • randomized controlled trial
  • intensive care unit
  • phase ii study
  • emergency department
  • disease activity
  • nk cells